Physician profile
David Morales
NPI 1407936818
$163,183.43
in general payments reported to CMS, 2019-2025
15 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $44K · 2021: $51K · 2022: $34K · 2023: $5,449 · 2024: $264 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,900 · Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,900.00 |
| Food and Beverage | $1,080.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $122,155.76 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Elutia, INC. | $37,111.16 | 2019-2022 | |
| Medtronic Vascular, INC. | $2,441.34 | 2019-2020 | |
| Medtronic, INC. | $757.59 | 2021-2025 | Invos, Simulus, Penditure |
| Abiomed | $126.27 | 2023 | Impella |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $119.37 | 2024 | |
| Edwards Lifesciences Corporation | $109.32 | 2021-2024 | Inspiris Resilia Aortic Valve |
| Dexcom, INC. | $109.09 | 2022 | |
| Genentech USA, INC. | $76.15 | 2019 | |
| Atricure, INC. | $65.85 | 2019 | |
| Lemaitre Vascular, INC. | $34.62 | 2025 | Restoreflow |
| Covidien LP | $31.47 | 2019 | |
| Allergan, INC. | $24.49 | 2020 | |
| Aquestive Therapeutics, INC. | $20.95 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.